LIPOCALIN-2 (LCN-2) IS A NOVEL MYOKINE THAT REDUCES LIPID ACCUMULATION AND INDUCES LIPOLYSIS IN ADIPOCYTES

dc.contributor.advisorBennett, Andrew J
dc.contributor.advisorTsintzas, Kostas
dc.contributor.authorAlsolami, Areej M
dc.date.accessioned2023-11-14T11:49:33Z
dc.date.available2023-11-14T11:49:33Z
dc.date.issued2023-10-15
dc.description.abstractLCN-2 is an acute phase protein, first identified as an adipokine secreted by adipose tissue. Contradictory experimental results show that LCN-2 is involved in pro- and anti-inflammatory states and can both increase and decrease insulin resistance. However, whilst the Lipocalin-2 protein is widely expressed in several tissues/cells, its expression has been poorly studied in skeletal muscle. Experiments in FRAME lab have demonstrated that the mRNA expression of LCN-2 is increased after exercise post 3-hr in vivo in 3 partipiants out of 6, and therefore its role in skeletal muscle following exercise needs to be investigated. We hypothesise that LCN-2 is a novel potential myokine, acting post exercise in an endocrine fashion that affects lipid metabolism. Methods Primary human myotubes were isolated from healthy volunteers and cultured to study LCN-2 expression and secretion in response to EPS stimulation and AICAR treatment. The lentiviral inducible vector pINDUCER20 was used to enable inducible overexpression of LCN-2 in human primary myotubes. Lastly, adipocytes were exposed to conditioned media (CM) derived from human myotubes that overexpress LCN-2 to study the crosstalk between muscle and adipose tissue. Results We found that LCN-2 mRNA expression was significantly upregulated in a time- dependant manner (2 h, 4 h, 16 h) by EPS (p<0.0001; 6-fold post-16 hr) and protein was secreted by human myotubes in response to 16 h of EPS (p<0.0001; 43% increase). Moreover, the level of LCN-2 secretion by myotubes increased in response to AICAR treatment for 48 h (p<0.0001; 3-fold increae). Lipid accumulation in adipocytes (3T3L-1) reduced significantly post-48 h when adipocytes (3T3L-1) were exposed to 50% CM derived from human myotubes that overexpress LCN-2 (p<0.0001; 3-fold). Moreover, a significant increase in release of glycerol (nmol/mg of cell protein) post48 h occurred when exposed to human myotube CM (p<0.001; 2- fold). Additionally, we found that ATGL protein was upregulated in response to LCN-2 containing conditioned medium (p<0.0001; ~ 4-fold). Conclusion We conclude that LCN-2 is a novel exercise-induced myokine that appears to induce lipolysis and decrease lipid accumulation in adipocytes.
dc.format.extent232
dc.identifier.urihttps://hdl.handle.net/20.500.14154/69691
dc.language.isoen
dc.publisherSaudi Digital Library
dc.subjectLipocalin-2
dc.subjectEPS
dc.subjectExercise
dc.subjectLipid accumulation
dc.subjectLipid metabolism
dc.subjectLipolysis
dc.subjectMuscle contraction
dc.subjectSkeletal muscle
dc.titleLIPOCALIN-2 (LCN-2) IS A NOVEL MYOKINE THAT REDUCES LIPID ACCUMULATION AND INDUCES LIPOLYSIS IN ADIPOCYTES
dc.typeThesis
sdl.degree.departmentLife Sciences
sdl.degree.disciplineMetabolic and Molecular Physiology
sdl.degree.grantorUniversity of Nottingham
sdl.degree.nameDoctor of philosphy

Files

Copyright owned by the Saudi Digital Library (SDL) © 2025